Reply to: "NNMT aggravates hepatic steatosis but alleviates liver injury in alcoholic liver disease" and "Two sides of NNMT in alcoholic and non-alcoholic fatty liver development"

J Hepatol. 2021 May;74(5):1253-1254. doi: 10.1016/j.jhep.2021.01.034. Epub 2021 Jan 30.

Authors

Qing Song¹, Jun Wang¹, Alexandra Griffiths¹, Zhenyuan Song²

Affiliations

¹ Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL, USA.
² Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL, USA. Electronic address: [email protected].

PMID: 33529671
DOI: 10.1016/j.jhep.2021.01.034

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Comment

MeSH terms

Humans
Liver
Liver Diseases, Alcoholic*
Nicotinamide N-Methyltransferase
Non-alcoholic Fatty Liver Disease* / etiology

Substances

Nicotinamide N-Methyltransferase
NNMT protein, human

Grants and funding